| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |